Celcuity Inc. Common Stock (CELC) Financials
Key financial figures for Celcuity Inc. Common Stock (Q3 2026).
REVTORPYK shipments began September 30, 2026, so Celcuity booked no product revenue in Q3: net loss was $73.3 million ($1.33 per share) on $77.3 million of operating expenses. No product revenue yet: REVTORPYK (gedatolisib) became commercially available on September 30, 2026, but no product reached providers or pharmacies before quarter end, so none was recognized in Q3. Loss widened as launch spending ramped: net loss was $73.3 million, or $1.33 per share, versus $43.8 million, or $0.92 per share, a year earlier. Non-GAAP adjusted net loss was $66.8 million, or $1.21 per share, versus $37.2 million, or $0.78 per share. SG&A drove the increase: total operating expenses were $77.3 million versus $42.8 million. On the outlook: Management expects current cash, cash equivalents and short-term investments to finance operations through 2029; the press release gave no revenue or expense guidance. Figures are for Q3 2026, as Celcuity reported them.
- Revenue
- $0
- Net Income
- -$73M
- EPS
- $-1.33
- Total Assets
- $727M
- Operating Cash Flow
- -$66M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $0 | -$73M | -$1.33 | -$66M | |
| Q2 FY2026 | $0 | -$79M | -$1.44 | -$55M | |
| Q1 FY2026 | $0 | -$53M | -$0.97 | -$55M | |
| Q4 FY2025 | $0 | -$51M | -$0.96 | -$36M | |
| Q3 FY2025 | $0 | -$44M | -$0.92 | -$45M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $0 | -$177M | -$3.79 | -$154M | |
| FY2024 | $0 | -$112M | -$2.83 | -$84M | |
| FY2023 | $0 | -$64M | -$2.69 | -$54M |
Frequently asked questions
What was Celcuity's revenue last quarter?
Celcuity reported revenue of $0.00 for Q3 FY2026.
Is Celcuity profitable?
Not in its most recent reported period. Celcuity reported a net loss of $73.3 million for Q3 FY2026.
How much free cash flow did Celcuity generate?
Celcuity generated free cash flow of -$66.2 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Celcuity Inc. Common Stock on SentiSense, with up to forty quarters and twenty fiscal years of history.